Michael Gosk
General Atlantic, L.p.
Assets Managed
$2.148B
Holdings
12
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-25.21%(2Q avg: -19.48%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in General Atlantic, L.p.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 12 positions.
Assets under management
The assets under management (AUM) of General Atlantic, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 2.148B in assets, with a quarterly growth rate of -25.21% and a 2-quarter average growth rate of -19.48%. The portfolio is managed by Michael Gosk, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
DLO Dlocal Ltd
| 28.17% | $605.137M 46.657M shares@ $12.97 avg price | |
CHYM Chime Financial Inc-cl A
| 18.54% | $398.194M 21.26M shares@ $18.74 avg price | |
XP Xp Inc - Class A
| 18.23% | $391.579M 20.566M shares@ $19.04 avg price | Decreased -9.39% |
ALKT Alkami Technology Inc
| 11.19% | $240.339M 15.337M shares@ $15.68 avg price | Increased 27.91% |
PHVS Pharvaris Nv
| 10.57% | $226.883M 8.031M shares@ $28.25 avg price | |
EWCZ European Wax Center Inc-a
| 3.53% | $75.779M 13.11M shares@ $5.79 avg price | |
RVMD Revolution Medicines Inc
| 3.21% | $68.833M 707,791 shares@ $97.26 avg price | Decreased -74.83% |
NRIX Nurix Therapeutics Inc
| 2.96% | $63.579M 4.102M shares@ $15.51 avg price | Decreased -16.23% |
CNTA Centessa Pharmaceuticals-adr
| 2.51% | $53.814M 1.355M shares@ $39.73 avg price | Decreased -77.85% |
RSKD Riskified Ltd-a
| 0.98% | $20.874M 5.325M shares@ $3.92 avg price |
1-10 of 12